Literature DB >> 17719651

Alternative activation of ruminant macrophages by Fasciola hepatica.

R J Flynn1, J A Irwin, M Olivier, M Sekiya, J P Dalton, G Mulcahy.   

Abstract

The helminth parasite, Fasciola hepatica, has a worldwide distribution and infects a wide variety of mammalian hosts, including ruminants and man. In response to infection, these hosts mount a type 2 helper (Th2) response that is highly polarized and results in the downregulation of type 1 helper (Th1) mechanisms. In a murine macrophage model F. hepatica induces alternative activation of macrophages. These macrophages differ from classically activated cells in that they preferentially use arginase instead of inducible nitric oxide synthase (iNOS) for metabolism of nitrogen. In this study we sought to characterize macrophage phenotype following stimulation of the ovine cell line MOCL7 with recombinant F. hepatica enzymes and crude parasite extracts. An in vitro model using the MOCL7 cell line was established and arginase levels in cells were used to determine the activation status of cells. Stimulation of this cell-line in vitro with F. hepatica products induces alternative activation. We have also found a chitinase-like protein in supernatants which is capable of differentiating alternatively activated from classically activated macrophages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719651     DOI: 10.1016/j.vetimm.2007.07.003

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  22 in total

1.  C-type lectins on macrophages participate in the immunomodulatory response to Fasciola hepatica products.

Authors:  Lorena Guasconi; Marianela C Serradell; Ana P Garro; Luciana Iacobelli; Diana T Masih
Journal:  Immunology       Date:  2011-05-20       Impact factor: 7.397

2.  Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.

Authors:  Ivelisse Martin; Kimberly Cabán-Hernández; Olgary Figueroa-Santiago; Ana M Espino
Journal:  J Immunol       Date:  2015-03-16       Impact factor: 5.422

3.  Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis.

Authors:  Ivana Ferreira; Danielle Smyth; Soraya Gaze; Ammar Aziz; Paul Giacomin; Nathalie Ruyssers; David Artis; Thewarach Laha; Severine Navarro; Alex Loukas; Henry J McSorley
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

4.  Proteomic analysis of Fasciola hepatica excretory and secretory products (FhESPs) involved in interacting with host PBMCs and cytokines by shotgun LC-MS/MS.

Authors:  Qing Liu; Si-Yang Huang; Dong-Mei Yue; Jin-Lei Wang; Yujian Wang; Xiangrui Li; Xing-Quan Zhu
Journal:  Parasitol Res       Date:  2016-11-19       Impact factor: 2.289

Review 5.  Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes.

Authors:  Stephen J Jenkins; Judith E Allen
Journal:  J Biomed Biotechnol       Date:  2010-01-26

6.  Possible role for Toll-like receptors in interaction of Fasciola hepatica excretory/secretory products with bovine macrophages.

Authors:  Robin J Flynn; Grace Mulcahy
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

Review 7.  Evasion of Host Immunity During Fasciola hepatica Infection.

Authors:  Robin J Flynn; Mayowa Musah-Eroje
Journal:  Methods Mol Biol       Date:  2020

8.  Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages.

Authors:  Olgary Figueroa-Santiago; Ana M Espino
Journal:  Infect Immun       Date:  2014-09-15       Impact factor: 3.441

9.  Toxoplasma gondii peroxiredoxin promotes altered macrophage function, caspase-1-dependent IL-1β secretion enhances parasite replication.

Authors:  Edward S Marshall; Hany M Elshekiha; Mohamed-Ali Hakimi; Robin J Flynn
Journal:  Vet Res       Date:  2011-06-27       Impact factor: 3.683

10.  The absence of MyD88 has no effect on the induction of alternatively activated macrophage during Fasciola hepatica infection.

Authors:  HongLin Luo; Weiyi Huang; Dongying Wang; Haoju Wang; Kui Nie
Journal:  BMC Immunol       Date:  2011-11-11       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.